Ra Pharmaceuticals, Inc. (7)

Browse by Contract Category

Contracts

Second Amendment to Lease Agreement, dated March 11, 2020, by and between Ra Pharmaceuticals, Inc. and HCP/King 87 CPD LLC (Filed With SEC on March 16, 2020)
Description of Capital Stock (Filed With SEC on February 27, 2020)
License Agreement, dated as of July 15, 2019, by and between the Registrant and Camurus AB (Filed With SEC on November 7, 2019)
Agreement and Plan of Merger, dated October 9, 2019, by and among UCB S.A., Franq Merger Sub, Inc. and Ra Pharmaceuticals, Inc (Filed With SEC on October 10, 2019)
Non-Employee Director Compensation Policy, effective April 1, 2019 (Filed With SEC on August 7, 2019)
Open Market Sale AgreementSM, dated as of May 9, 2019, by and between Ra Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on May 9, 2019)
Underwriting Agreement, dated July 23, 2019, between the Company and Jefferies LLC, BMO Capital Markets Corp. and Stifel, Nicolaus & Company, Incorporated, as representatives of... (Filed With SEC on July 26, 2019)